GPCR
Price
$36.41
Change
+$1.91 (+5.54%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.21B
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR

Header iconGPCR Comparison
Open Charts GPCRBanner chart's image
Structure Therapeutics
Price$36.41
Change+$1.91 (+5.54%)
Volume$19.45K
Capitalization2.21B
GPCR Comparison Chart in %
GPCR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.15B. The market cap for tickers in the group ranges from 58 to 106.82B. VRTX holds the highest valuation in this group at 106.82B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -2%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 64%. MRSN experienced the highest price growth at 211%, while KRRO experienced the biggest fall at -80%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 53%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was 443%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 79
Price Growth Rating: 57
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 5 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (GPCR: $36.42)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 1 FA rating(s) are green while.

  • GPCR’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 5 TA indicator(s) are bullish.

  • GPCR’s TA Score: 5 bullish, 4 bearish.

Price Growth

GPCR (@Biotechnology) experienced а +1.39% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR
Capitalization2.21B
EBITDA-218.56M
Gain YTD34.292
P/E RatioN/A
Revenue0
Total Cash786M
Total Debt7.68M
TECHNICAL ANALYSIS
Technical Analysis
GPCR
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 27 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USBLX29.79N/A
N/A
Victory Growth and Tax Strategy
ATGRX13.82N/A
N/A
American Century International Gr R
PACOX65.34N/A
N/A
T. Rowe Price U.S. Equity Research Adv
SEKRX22.75N/A
N/A
DWS Emerging Markets Equity R6
JERSX11.92-0.09
-0.75%
Janus Henderson Global Real Estate S

GPCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CLDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+5.57%
CLDX - GPCR
45%
Loosely correlated
-2.58%
SYRE - GPCR
45%
Loosely correlated
+0.83%
IMTX - GPCR
44%
Loosely correlated
N/A
VKTX - GPCR
44%
Loosely correlated
-4.56%
ARWR - GPCR
42%
Loosely correlated
-3.71%
More